Related Experiment Video

Updated: Aug 7, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

New use for radioisotope in prostate cancer

Roxanne Nelson

    The Lancet. Oncology
    |July 15, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
    06:54

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

    Published on: September 3, 2013

    Related Experiment Videos

    Last Updated: Aug 7, 2026

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
    06:54

    MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

    Published on: September 3, 2013

    Related Concept Videos

    Isotopes and Radioisotopes01:28

    Isotopes and Radioisotopes

    In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
    An isotope containing more...
    Positron Emission Tomography01:29

    Positron Emission Tomography

    Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
    One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

    Articles linked to this work by shared authors, journal, and citation graph.

    2020: Deadliest Year for Gun Violence in Decades.

    The American journal of nursing·2021

    Nursing Homes in the Crosshairs.

    The American journal of nursing·2020

    Aid in Dying: Implications for Nurses.

    The American journal of nursing·2020

    Nursing Innovation.

    The American journal of nursing·2020

    Stem Cell Joint Therapy: Promising, but Not Ready for Prime Time.

    The American journal of nursing·2019

    Trends in Home Care-the Coming Resource Crisis.

    The American journal of nursing·2019

    Challenges in the use of the European Society for Radiotherapy and Oncology-European Organisation for Research and Treatment of Cancer oligometastatic disease classification system in ovarian cancer.

    The Lancet. Oncology·2026

    Tumour-infiltrating lymphocytes and breast radiotherapy: perspectives from the International Immuno-Oncology Biomarker Working Group.

    The Lancet. Oncology·2026

    Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.

    The Lancet. Oncology·2026

    Manual, digital, and AI tumour-infiltrating lymphocyte scoring: a secondary analysis of the APHINITY randomised trial.

    The Lancet. Oncology·2026

    High-dose radiotherapy in patients with high-risk prostate cancers treated with long-term androgen deprivation therapy (GETUG AFU 18): a randomised, phase 3 trial.

    The Lancet. Oncology·2026

    SHR-A2102, a nectin-4 directed antibody-drug conjugate, in patients with pretreated advanced solid tumours: a multicentre, single-arm, phase 1 trial.

    The Lancet. Oncology·2026

    Comparison of Esophageal Dose Parameters in Breast Cancer Radiotherapy With and Without Esophageal Contouring.

    Cureus·2026

    Staged Flexible Transurethral Lithotripsy After Robot-Assisted Partial Nephrectomy for Concomitant Renal Cell Carcinoma and Ipsilateral Nephrolithiasis: A Case Report.

    Cureus·2026

    Mechanistic insights into Strontium-90 superficial radiotherapy in keloids: senescence-associated changes and ECM remodeling across cell-matrix scales.

    Frontiers in pharmacology·2026

    Three-Dimensional Soft Tissue Reconstructive Planning in Orthoplastic Oncology: A Systematic Review.

    Cureus·2026

    [Role and Potential Mechanisms of Peroxisome Proliferator-Activated Receptor α in Ultraviolet B Radiation-Induced Skin Damage].

    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2026

    A clinical evaluation of HyperSight CBCT enhanced offline adaptive breast radiotherapy.

    Frontiers in oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us